Delving into the Latest Updates on Cohen Global Ltd. with Synapse

概览

疾病领域	数量

内分泌与代谢疾病	1

排名前五的药物类型	数量

合成多肽	1

排名前五的靶点	数量

PTP1B(蛋白酪氨酸磷酸酶-1B)	1

关联

1

项与 Cohen Global Ltd. 相关的药物

MD-18

靶点

PTP1B

作用机制

PTP1B modulators

在研机构

Radella Pharmaceuticals, LLC. [+1]

原研机构

Cohen Global Ltd. [+1]

在研适应症

糖尿病 [+1]

非在研适应症-

最高研发阶段临床1期

首次获批国家/地区-

首次获批日期-

2

项与 Cohen Global Ltd. 相关的临床试验

NCT06739707

/ Not yet recruiting临床1期

A Multiple Dose, Randomized, Placebo-controlled, Dose-escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered MD-18 for Healthy Subjects with Overweight or Obesity

A Multiple Dose, Randomized, Placebo-controlled, Dose-escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered MD-18 for healthy subjects with overweight or obesity

开始日期2024-12-01

申办/合作机构

Cohen Global Ltd.

NCT06259903

/ Active, not recruiting临床1期

A Single Center, Single Dose, Double-blind, Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability and Pharmacokinetics of Subcutaneously Administered MD-18 in Healthy Subjects.

A Single Center, Single Dose, Double-blind, Randomized, Placebo-controlled Dose-Escalating Study to Evaluate Safety, Tolerability and Pharmacokinetics of Subcutaneously Administered MD-18 in healthy subjects.

开始日期2024-05-07

申办/合作机构

Cohen Global Ltd.

100 项与 Cohen Global Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Cohen Global Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Cohen Global Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Cohen Global Ltd. 相关的转化医学

登录后查看更多信息